Alex Vallianos
About Alex Vallianos
Alex Vallianos is the Director of National Accounts at BeiGene, with extensive experience in business development within the biotechnology industry, particularly in Market Access, Genomic diagnostics, and Oncology.
Current Role at BeiGene
Alex Vallianos is the Director of National Accounts at BeiGene, a Biotechnology company. Since March 2019, he has been responsible for overseeing national accounts, ensuring effective market access and strategic partnerships within the organization. His role requires a deep understanding of the biotechnology industry, particularly in market access and genomic diagnostics.
Previous Positions at Exelixis and bioTheranostics
Before joining BeiGene, Alex Vallianos worked at Exelixis as the Senior Director of GPO and Strategic Partners from 2016 to 2019. Prior to that, he served as National Director of Key Accounts and KOL Management at bioTheranostics, Inc. for 11 months in 2015. He also held the position of National Sales Director, East and Commercial Lead BCI at bioTheranostics, Inc., from 2014 to 2015. These roles underline his capacity to manage strategic partnerships and key opinion leader relationships within the biotechnology sector.
Experience at Genomic Health and Genentech BioOncology
Alex Vallianos accrued significant experience at Genomic Health, Inc. as Senior Strategic Market Manager from 2011 to 2014. This role emphasized his expertise in market management and strategic positioning. Before that, he spent six years at Genentech BioOncology as a Thought Leader Liaison, where he strengthened his expertise in building physician networks and supporting oncology initiatives.
Early Career in Biotechnology and Pharmaceuticals
Alex Vallianos started his career at Stuart/ICI Pharmaceuticals and Ciba-Geigy Pharmaceuticals in the late 1980s, serving as a Medical Representative. He later moved to RPR Oncology as Sr. Oncology Specialist and then to Aventis Oncology as a National Account Manager. His diverse roles within these companies laid a strong foundation in the biotechnology and pharmaceutical industries, particularly in oncology.
Education Background
Alex Vallianos completed his Bachelor's degree in Business Administration at the University of North Carolina at Chapel Hill, studying there from 1978 to 1983. This educational foundation has supported his extensive career in business development within the biotechnology industry.